Wexford Capital’s ProPhase Labs PRPH Stock Holding History

Wexford Capital’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-152,561	Closed	-$617K	–	306
2025 Q1	$617K	Buy	+152,561	New	+$700K	0.16%	104

Other funds holding PRPH

Sykon Capital Harrison, New York $300M AUM 16.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wexford Capital's PRPH Position: Q2 2025 in Review

Wexford Capital sold out of ProPhase Labs (PRPH) in Q2 2025, closing a stake of 152,561 shares — an estimated $617K sold.

Wexford Capital first reported a position in PRPH in Q1 2025 and held it in 1 quarter. The position peaked at $617K in Q1 2025. 33 funds tracked by Wall St. Rank hold PRPH as of Q2 2025.

Wexford Capital reported no remaining ProPhase Labs position as of Q2 2025 after selling out during the quarter.
Wexford Capital sold 152,561 ProPhase Labs shares in Q2 2025, an estimated $617K.
Wexford Capital first reported a position in ProPhase Labs in Q1 2025 and held it in 1 quarter.
Wexford Capital's ProPhase Labs position peaked at $617K in Q1 2025.
33 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2025.

Based on Wexford Capital's 13F filing for Q2 2025, filed 14 Aug 2025.